JNJ vs UNH
Johnson & Johnson vs UnitedHealth Group Incorporated · Updated Aug 11, 2026
JNJ — 14 winsUNH — 9 wins
Price Performance
JNJ +51.42%UNH +61.75%
Performance
| JNJ | UNH | |
|---|---|---|
| 1 Month | +1.36% | -3.90% |
| 3 Months | +17.69% | +7.39% |
| 6 Months | +8.54% | +51.95% |
| YTD | +25.87% | +23.61% |
| 1 Year | +51.86% | +66.03% |
| 3 Year | +69.04% | -12.54% |
| 5 Year | +88.26% | +15.14% |
Yearly Returns
| YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | +26.9% | +43.7% | -9.6% | -12.0% | +3.0% | +9.3% | +7.8% | +14.2% | -7.3% | +20.6% | +14.7% | -1.7% |
| UNH | +21.4% | -35.6% | -6.2% | +1.5% | +5.5% | +43.7% | +19.9% | +20.7% | +12.6% | +36.5% | +37.4% | +16.7% |
Valuation
| JNJ | UNH | |
|---|---|---|
| P/E Ratio | 30.11 | 30.82 |
| Forward P/E | 11.17 | 9.99 |
| PEG Ratio | 2.75 | 2.08 |
| P/S Ratio | 6.48 | 0.82 |
| P/B Ratio | 7.70 | 3.56 |
| EV/EBITDA | 19.63 | 18.25 |
Financials
| JNJ | UNH | |
|---|---|---|
| EPS (TTM) | $8.65 | $13.24 |
| Gross Margin | +71.49% | +22.74% |
| Operating Margin | +26.58% | +8.05% |
| Net Margin | +21.76% | +5.62% |
| ROE | +25.92% | +11.59% |
| ROA | +10.47% | +3.85% |
| Debt/Equity | 0.22 | 0.75 |
Growth
| JNJ | UNH | |
|---|---|---|
| Revenue Growth YoY | +9.91% | +1.96% |
| Revenue Growth QoQ | -2.04% | -1.32% |
| EPS Growth YoY | -52.86% | +0.73% |
| EPS Growth QoQ | +1.90% | +62627.30% |
Technical
| JNJ | UNH | |
|---|---|---|
| RSI (14) | 54.17 | 44.22 |
| % From 20-Day SMA | +1.41% | -2.67% |
| % From 50-Day SMA | +4.89% | -1.27% |
| % From 200-Day SMA | +14.05% | +17.75% |
| % From 52-Week High | -5.25% | -11.60% |
| % From 52-Week Low | +52.87% | +70.38% |
Analyst Ratings
JNJ
Buy(22 analysts)
Strong SellHoldStrong Buy
Price Target
$282.08
+9.40% upside
UNH
Buy(42 analysts)
Strong SellHoldStrong Buy
Price Target
$473.89
+15.92% upside
Overview
| JNJ | UNH | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical - Healthcare Plans |
| Exchange | NYSE | NYSE |
| Market Cap | $624.74B | $369.69B |
| Shares Outstanding | 2.41B | 908.1M |
| Avg Volume (10D) | 7.60M | 4.51M |
| Dividend Yield | 2.02% | 2.20% |
Frequently Asked Questions
Is JNJ or UNH a better buy right now?
Based on 23 comparable metrics, JNJ leads in 14 categories while UNH leads in 9. JNJ has a consensus analyst rating with 22 analysts covering the stock. Neither stock should be purchased based on a single comparison — consider your investment goals and risk tolerance.
Which stock has better performance, JNJ or UNH?
Over the past year, JNJ returned +51.86% compared to UNH's +66.03%. In the short term (1 month), JNJ returned +1.36% vs UNH's -3.90%.
Is JNJ or UNH more expensive?
JNJ trades at a P/E of 30.11 compared to UNH's 30.82. On a price-to-sales basis, JNJ trades at 6.48x vs UNH's 0.82x. Forward P/E: JNJ at 11.17 vs UNH at 9.99.
Which stock has higher growth, JNJ or UNH?
JNJ's revenue grew +9.91% year-over-year compared to UNH's +1.96%. EPS growth: JNJ at -52.86% vs UNH at +0.73%.
Do JNJ and UNH pay dividends?
JNJ pays a dividend with a yield of 2.02%. UNH pays a dividend with a yield of 2.20%.
Which stock do analysts prefer, JNJ or UNH?
JNJ has 22 analysts with a target price of $282.08 (+9.40% upside). UNH has 42 analysts with a target of $473.89 (+15.92% upside).
Data updated daily. All comparisons based on latest available market data. Not investment advice.